Substance use disorders (SUDs) are major causes of morbidity and mortality in the United States. SUDs commonly co-occur with other psychiatric and physical illness and often require management by an addiction specialist to comprehensively address patients’ complex needs. The American Board of Medical Specialties (ABMS) offers two pathways leading to addiction subspecialty board certification: addiction psychiatry (American Board of Psychiatry and Neurology) and addiction medicine (American Board of Preventive Medicine). We explore the history of the distinct but overlapping practices of addiction medicine and addiction psychiatry and describe the unique contributions of each field. Specifically, we review skill sets, specialty training, and career outcomes for physicians specializing in the assessment and management of SUDs. We conclude by highlighting collaboration between the two specialties and offer a shared vision for the future of addiction specialty care.
Substance Abuse and Mental Health Services Administration (SAMSHA). Key substance use and mental health indicators in the United States: Results from the 2018 National Survey on Drug Use and Health. Rockville, MD.: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2019.
KesslerRC, BerglundP, DemlerO, JinR, MerikangasKR, WaltersEE.Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593–602.
4.
HendricksonEL.Designing, Implementing, and Managing Treatment Services for Individuals with Co-Occurring Mental Health and Substance Use Disorders: Blueprints for Action. Binghamton, New York: Haworth; 2006.
Clare Bonnema (American Board of Preventive Medicine (ABPM) Manager of Communications and Stakeholder Engagement). Personal Communication. In: December 2, 2020.
7.
ChristieC, BakerC, CooperR, KennedyPJ, MadrasB, BondiP.The president's commission on combating drug addiction and the opioid crisis. Washington, DC, US Government Printing Office; Nov. 2017. 1.
8.
MannRE, SmartRG, GovoniR.The epidemiology of alcoholic liver disease. Alcohol Res Health. 2003;27(3):209–219.
RiuttanenA, JänttiSJ, MattilaVM.Alcohol use in severely injured trauma patients. Sci Rep. 2020;10(1):1–8.
11.
MurrayCJ, LopezAD.Measuring the global burden of disease. N Engl J Med. 2013;369(5):448–457.
12.
DegenhardtL, CharlsonF, FerrariA, . The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Psychiatry. 2018;5(12):987–1012.
13.
Centers for Disease Control and Prevention (CDC). Data and Statistics About Opioid Use During Pregnancy. https://www.cdc.gov/pregnancy/opioids/data.html. Published 2020. Accessed August 18, 2020.
14.
ShantnaK, ChaudhuryS, VermaA, SinghA.Comorbid psychiatric disorders in substance dependence patients: A control study. Ind Psychiatry J. 2009;18(2):84–87.
15.
DarcinAE, NurmedovS, NoyanCO, YilmazO, DilbazN.Psychiatric comorbidity among inpatients in an addiction clinic and its association with the process of addiction. Dusunen Adam. 2015;28(3):196–203.
16.
AsnaaniA, ChelminskiI, YoungD, ZimmermanM.Heterogeneity of borderline personality disorder: do the number of criteria met make a difference?J Pers Disord. 2007;21(6):615–625.
17.
BradyKT, HaynesLF, HartwellKJ, KilleenTK.Substance use disorders and anxiety: a treatment challenge for social workers. Soc Work Public Health. 2013;28(3–4):407–423.
18.
ComptonWM, ThomasYF, StinsonFS, GrantBF.Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2007;64(5):566–576.
19.
Flórez-SalamancaL, Secades-VillaR, BudneyAJ, García-RodríguezO, WangS, BlancoC.Probability and predictors of cannabis use disorders relapse: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug Alcohol Depend. 2013;132(1–2):127–133.
20.
GonzálezE, AriasF, SzermanN, VegaP, MesiasB, BasurteI.Coexistence between personality disorders and substance use disorder. Madrid study about prevalence of dual pathology. Actas Esp Psiquiatr. 2019;47(6):218–228.
21.
HartzSM, PatoCN, MedeirosH, . Comorbidity of severe psychotic disorders with measures of substance use. JAMA Psychiatry. 2014;71(3):248–254.
22.
PettinatiHM, O'BrienCP, DundonWD.Current status of co-occurring mood and substance use disorders: a new therapeutic target. Am J Psychiatry. 2013;170(1):23–30.
23.
Wolitzky-TaylorK, OperskalskiJT, RiesR, CraskeMG, Roy-ByrneP.Understanding and treating comorbid anxiety disorders in substance users: review and future directions. J Addict Med. 2011;5(4):233–247.
24.
PennayA, CameronJ, ReichertT, . A systematic review of interventions for co-occurring substance use disorder and borderline personality disorder. J Subst Abuse Treat. 2011;41(4):363–373.
25.
TrullTJ, FreemanLK, VebaresTJ, ChoateAM, HelleAC, WycoffAM.Borderline personality disorder and substance use disorders: an updated review. Borderline Personal Disord Emot Dysregul. 2018;5(1):15
26.
FreedCR.Addiction medicine and addiction psychiatry in America: the impact of physicians in recovery on the medical treatment of addiction. Contemp Drug Probl. 2007;34(1):111–135.
27.
FreedCR.Addiction medicine and addiction psychiatry in America: commonalities in the medical treatment of addiction. Contemp Drug Probl. 2010;37(1):139–163.
28.
O'ConnorPG, SokolRJ, D'OnofrioG.Addiction medicine: the birth of a new discipline. JAMA Intern Med. 2014;174(11):1717–1718.
29.
RonisR.Addiction psychiatry. In: AminoffMJ, FaulknerLR, eds. The American Board of Psychiatry and Neurology: Looking Back and Moving Ahead. Arlington, VA: American Psychiatric Publishing; 2012:119–128.
Accreditation Council of Graduate Medical Education (ACGME). Addiction Psychiatry Programs. Academic Year 2020-2021, United States. https://apps.acgme.org/ads/Public/Reports/Report/1. Published 2020. Accessed December 5, 2020.
35.
American Academy of Addiction Psychiatry (AAAP). Fellowship and Programs. https://www.aaap.org/fellowship/. Accessed December 5, 2020.
American Academy of Addiction Psychiatry (AAAP). About AAAP. https://www.aaap.org/about/. Accessed July 15, 2020.
40.
PlawmanA, KlieKA, WalshJ.Redesigning Addiction Fellowship Education During COVID-19 [Webinar]. In Innovative Programs in Addiction Education. American Academy of Addiction Pyschiatry and American and American College of Academic Addiction Medicine; June 16, 2020.
41.
HoeferM, EdensEL.Introduction to Innovative Programs in Addiction Education Series [Webinar]. In. Innovative Programs in Addiction Education. American Academy of Addiction Pyschiatry and American and American College of Academic Addiction Medicine; November 14, 2019.
